Literature DB >> 31593704

7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.

Enxia Zhang1, Jiasi Liu1, Lei Shi1, Xin Guo1, Ze Liang1, Jiaxin Zuo1, Hong Xu2, Huaxin Wang2, Xiaohong Shu1, Shanshan Huang1, Shubiao Zhang3, Xiaohui Kang4, Yuhong Zhen5.   

Abstract

AIMS: To investigate the effect of 7-O-geranylquercetin (GQ), a derivative of quercetin (Q), on reversing drug resistance in breast cancer MCF-7/ADR cells and reveal the mechanisms related to P-glycoprotein (P-gp). MAIN
METHODS: Cell viability was determined by MTT assay. Accumulation of adriamycin (ADR) in cells was determined by confocal fluorescence microscope and microplate reader while that of rhodamine (Rh) was measured by flow cytometry. Expression levels of P-gp and MDR1 gene in cells were detected by western blot and Real-Time PCR, respectively. Molecular docking of GQ and Q with P-gp was conducted using AutoDock program. Xenograft model was established by inoculating MCF-7/ADR cells in BALB/c-nude mice. Tumor bearing mice were administered with ADR via tail vein injection and/or GQ (Q) by gavage. Expression levels of P-gp in tissues were detected by western blot and immunohistochemistry. KEY
FINDINGS: GQ could reverse drug resistance of MCF-7/ADR cells to ADR. GQ inhibited the efflux of ADR by down-regulating the expression of P-gp protein and its encoding gene MDR1 in MCF-7/ADR cells. Molecular modeling showed that GQ matched with P-gp better than Q. GQ enhanced the antitumor effects of ADR and decreased the expression of P-gp in mice and its activities were higher than that of Q. GQ could reverse drug resistance of MCF-7/ADR cells by down-regulating the expression of P-gp in vitro and in vivo. SIGNIFICANCES: The reversal effect of GQ on P-gp-mediated drug resistance indicates its potential as a reversal agent for drug resistance in cancer chemotherapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7-O-Geranylquercetin; Adriamycin; Drug resistance; MCF-7/ADR; P-gp

Mesh:

Substances:

Year:  2019        PMID: 31593704     DOI: 10.1016/j.lfs.2019.116938

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

2.  The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters.

Authors:  Wenjie Huang; Fang Wen; Peixing Gu; Jiatong Liu; Yun Xia; Ye Li; Jiayu Zhou; Siyuan Song; Shuai Ruan; Suping Gu; Xiaoxue Chen; Peng Shu
Journal:  Chin Med       Date:  2022-08-09       Impact factor: 4.546

Review 3.  Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment.

Authors:  Kumari Sunita Prajapati; Sanjay Gupta; Shashank Kumar
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer.

Authors:  Yuling Chen; Xiaohong Li; Lei Shi; Pengfei Ma; Wei Wang; Nan Wu; Youlin Gan; Xu Han; Shanshan Huang; Xiaohui Kang; Shuxin Liu; Yuhong Zhen
Journal:  Aging (Albany NY)       Date:  2022-09-14       Impact factor: 5.955

5.  Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.

Authors:  Wenbin Xu; Shangdan Xie; Xin Chen; Shuya Pan; Hongfei Qian; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2021-02-15       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.